Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steen Knudsen

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Plos One|March 24, 2017
Clinical validation of chemotherapy predictors developed on global microRNA expression in the NCI60 cell line panel tested in ovarian cancerKira Philipsen Prahm, Claus Høgdall, Mona Aarenstrup Karlsen, et al.
Cells|July 9, 2022
A Signature of Exaggerated Adipose Tissue Dysfunction in Type 2 Diabetes Is Linked to Low Plasma Adiponectin and Increased Transcriptional Activation of Proteasomal Degradation in MuscleRugivan Sabaratnam, Vibe Skov, Søren K Paulsen, et al.
Plos One|September 14, 2022
Stenoparib, an inhibitor of cellular poly (ADP-ribose) polymerases (PARPs), blocks in vitro replication of SARS-CoV-2 variantsKatherine E Zarn, Sierra A Jaramillo, Anthony R Zapata, et al.
Clinical Chemistry|September 20, 2011
Fibulin-1 is a marker for arterial extracellular matrix alterations in type 2 diabetesClaudia Cangemi, Vibe Skov, Michael Kjaer Poulsen, et al.
Mbio|January 20, 2021
Stenoparib, an Inhibitor of Cellular Poly(ADP-Ribose) Polymerase, Blocks Replication of the SARS-CoV-2 and HCoV-NL63 Human Coronaviruses <i>In Vitro</i>Nathan E Stone, Sierra A Jaramillo, Ashley N Jones, et al.
Breast Cancer (Tokyo, Japan)|October 27, 2019
Prediction of fulvestrant efficacy in patients with advanced breast cancer: retrospective-prospective evaluation of the predictive potential of a multigene expression assayTroels Dreier Christensen, Anna Sofie Kappel Buhl, Ib Jarle Christensen, et al.
Breast Cancer Research and Treatment|August 13, 2018
Predicting efficacy of epirubicin by a multigene assay in advanced breast cancer within a Danish Breast Cancer Cooperative Group (DBCG) cohort: a retrospective-prospective blinded studyAnna Sofie Kappel Buhl, Troels Dreier Christensen, Ib Jarle Christensen, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|February 6, 2010
Using molecular classification to predict gains in maximal aerobic capacity following endurance exercise training in humansJames A Timmons, Steen Knudsen, Tuomo Rankinen, et al.
Nature Immunology|March 30, 2022
B lymphocyte-derived acetylcholine limits steady-state and emergency hematopoiesisMaximilian J Schloss, Maarten Hulsmans, David Rohde, et al.
European Journal of Cancer (Oxford, England : 1990)|July 21, 2022
Paediatric Strategy Forum for medicinal product development of multi-targeted kinase inhibitors in bone sarcomas: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug AdministrationAndrew Dj Pearson, Nathalie Gaspar, Katherine Janeway, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Plos One|March 24, 2017
Clinical validation of chemotherapy predictors developed on global microRNA expression in the NCI60 cell line panel tested in ovarian cancerKira Philipsen Prahm, Claus Høgdall, Mona Aarenstrup Karlsen, et al.
Cells|July 9, 2022
A Signature of Exaggerated Adipose Tissue Dysfunction in Type 2 Diabetes Is Linked to Low Plasma Adiponectin and Increased Transcriptional Activation of Proteasomal Degradation in MuscleRugivan Sabaratnam, Vibe Skov, Søren K Paulsen, et al.
Plos One|September 14, 2022
Stenoparib, an inhibitor of cellular poly (ADP-ribose) polymerases (PARPs), blocks in vitro replication of SARS-CoV-2 variantsKatherine E Zarn, Sierra A Jaramillo, Anthony R Zapata, et al.
Clinical Chemistry|September 20, 2011
Fibulin-1 is a marker for arterial extracellular matrix alterations in type 2 diabetesClaudia Cangemi, Vibe Skov, Michael Kjaer Poulsen, et al.
Mbio|January 20, 2021
Stenoparib, an Inhibitor of Cellular Poly(ADP-Ribose) Polymerase, Blocks Replication of the SARS-CoV-2 and HCoV-NL63 Human Coronaviruses <i>In Vitro</i>Nathan E Stone, Sierra A Jaramillo, Ashley N Jones, et al.
Breast Cancer (Tokyo, Japan)|October 27, 2019
Prediction of fulvestrant efficacy in patients with advanced breast cancer: retrospective-prospective evaluation of the predictive potential of a multigene expression assayTroels Dreier Christensen, Anna Sofie Kappel Buhl, Ib Jarle Christensen, et al.
Breast Cancer Research and Treatment|August 13, 2018
Predicting efficacy of epirubicin by a multigene assay in advanced breast cancer within a Danish Breast Cancer Cooperative Group (DBCG) cohort: a retrospective-prospective blinded studyAnna Sofie Kappel Buhl, Troels Dreier Christensen, Ib Jarle Christensen, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|February 6, 2010
Using molecular classification to predict gains in maximal aerobic capacity following endurance exercise training in humansJames A Timmons, Steen Knudsen, Tuomo Rankinen, et al.
Nature Immunology|March 30, 2022
B lymphocyte-derived acetylcholine limits steady-state and emergency hematopoiesisMaximilian J Schloss, Maarten Hulsmans, David Rohde, et al.
European Journal of Cancer (Oxford, England : 1990)|July 21, 2022
Paediatric Strategy Forum for medicinal product development of multi-targeted kinase inhibitors in bone sarcomas: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug AdministrationAndrew Dj Pearson, Nathalie Gaspar, Katherine Janeway, et al.
Pageof 5